Am J Transplant, Volume 20, Suppl 3 Archives - Page 150 of 223 - ATC Abstracts

2020 American Transplant Congress
Relative Transplant Center Organ Volumes are Associated with Patient and Graft Survival
J. T. Adler, T. C. Tsai, S. K. Malek, S. G. Tullius, J. S. Weissman
Surgery, Brigham and Women's Hospital, Boston, MA
*Purpose: Transplant programs differ in relative volume of kidney and liver transplants. While there is a known volume-outcome relationship for organ-specific transplantation at an institutional…
2020 American Transplant Congress
Prevalence, Prognosis and Predictors of Neurological Complications after Heart Transplantation
C. Caraviello, D. Harsanyi, L. Trevizan, F. Bacal, S. Mangini
Cardiology, Hospital Israelita Albert Einstein, São Paulo, Brazil
*Purpose: Heart transplantation (HT) is considered the gold-standard treatment for end-stage heart failure. In spite of its innumerous benefits, this therapy still involves complications. Among…
2020 American Transplant Congress
Characterization of Donor/Recipient Citizenship Status in Adult Heart Transplantation: A UNOS Registry Analysis
K. Yang¹, D. Miklin¹, J. Pizula¹, P. Genyk¹, G. Liu², A. Lee¹, S. Nuno¹, S. Hashmi¹, J. Nattiv², A. Kiankhooy³, L. Grazette², M. Fong², J. Rahman², K. Pandya², D. Vucicevic⁴, J. Li¹, P. Kingsford¹, P. Banankhah², R. Chand⁵, A. Wolfson⁶, S. Shah¹, A. Salimbangon⁷, C. Lum⁸, E. C. Depasquale², A. S. Vaidya²
¹Keck Medicine of USC, Los Angeles, CA, ²Cardiology, Keck Medicine of USC, Los Angeles, CA, ³Cardiothoracic Surgery, Keck Medicine of USC, Los Angeles, CA, ⁴Newark Beth-Israel Medical Center, Newark, NJ, ⁵Harbor-UCLA Medical Center, Torrance, CA, ⁶University of Arizona Sarver Heart Center, Tucson, AZ, ⁷UCLA Medical Center, Los Angeles, CA, ⁸The Queen's Medical Center, Honolulu, HI
*Purpose: There is a paucity of data describing heart transplant donor and recipient status. We therefore sought to examine the medical and demographic characteristics, and…
2020 American Transplant Congress
Morbidity in Lung Transplant for Connective Tissue Disease
S. Minkove¹, E. Bush², P. Shah¹
¹Pulmonary and Critical Care, Johns Hopkins, Baltimore, MD, ²Thoracic Surgery, Johns Hopkins, Baltimore, MD
*Purpose: To evaluate the post-lung transplant comorbidities of patients with connective tissue disease (CTD) compared with an age-matched cohort of patients transplanted for idiopathic pulmonary…
2020 American Transplant Congress
Chronic Lymphocytic Leukemia in a Lung Transplant Recipient
A. Arjuna¹, M. T. Olson², S. Tokman¹, S. Biswas Roy¹, M. A. Smith¹, R. M. Bremner¹, R. Walia¹
¹Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, ²University of Arizona College of Medicine - Phoenix, Phoenix, AZ
*Purpose: Malignancy is generally a contraindication to lung transplantation (LTx). Few reports describe clinical outcomes in patients undergoing solid-organ transplantation with indolent hematologic malignancy. We…
2020 American Transplant Congress
The Outcomes of Pancreas Transplantation from Pediatric Donors: A Single Center Experience
J. Choi, Y. Ko, H. Kwon, S. Shin, Y. Kim, D. Han
Division of Kidney & Pancreas Transplantation, Department of Surgery, Asan Medical Center, Seoul, Korea, Republic of
*Purpose: For increasing pancreas donor pool, the use of pediatric donors for pancreas transplantation is considered as a suitable option. However, the following questions still…
2020 American Transplant Congress
Assessing Providers’ Accuracy in Predicting Early Readmission after Kidney and Liver Transplantation
K. Maroney, Z. Wang, R. Lynch, A. Adams, R. Patzer, J. Hogan
Emory University, Atlanta, GA
*Purpose: Predictive models capable of identifying patients at risk for readmission are in development. However, it is unknown how accurate clinicians are at predicting early…
2020 American Transplant Congress
Rouleaux Formation in Human Livers During Normothermic Machine Perfusion
M. Harris¹, S. Raigani², C. Albert³, M. Reschke³, C. Carroll², J. T. Langford¹, C. Edwards⁴, D. Mulligan⁴, D. Haakinson¹, K. Uygun², H. Yeh², G. Tietjen¹
¹Division of Transplantation, Yale New Haven Hospital, Yale School of Medicine, New Haven, CT, ²Division of Transplant Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ³Yale School of Engineering and Applied Science, New Haven, CT, ⁴Surgery, Division of Transplantation, Yale New Haven Hospital, Yale School of Medicine, New Haven, CT
*Purpose: We recently discovered that red blood cells form rouleaux plugs in human kidney vasculature during normothermic machine perfusion (NMP) and are associated with poor…
2020 American Transplant Congress
Targeting CD62 – CD162 Signaling with a Soluble Form of a Tandem-PSGL-1 in a Murine Model of Hindlimb Transplantation
K. Kadono¹, F. Messner², Y. Guo², B. Oh², G. Brandacher², J. W. Kupiec-Weglinski¹
¹Liver Transplant Surgery, UCLA, Los Angeles, CA, ²Plastic and Reconstructive Surgery, Johns Hopkins University School of Medicine, Baltimore, MD
*Purpose: Static cold storage (SCS) times for organs and tissues are currently limited to hours. Once outside the body, tissues lack oxygen and nutrient supply…
2020 American Transplant Congress
Comparison of Basiliximab for Induction Therapy in Kidney Transplant Recipients on Post-Operative Days 0 and 4 versus Post-Operative Days 0 and 3
C. Schardt, R. Yau, A. Burgos, C. Tunwar
Pharmacy, CHI St. Luke's Health Baylor St. Luke's Medical Center, Houston, TX
*Purpose: Current dosing recommendations for the administration of basiliximab on post-operative days (POD) 0 and 4 stem from two phase 3 renal transplant studies. Limited…